Ropes & Gray advised Xeris Biopharma Holdings on the transaction. Xeris Biopharma Holdings, Inc. (Nasdaq:XERS) (Xeris), a biopharmaceutical company, announced that it has entered into an exclusive worldwide...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Xeris Biopharma Holdings on the deal. Xeris Biopharma Holdings announced a platform research evaluation, collaboration and option agreement with Regeneron Pharmaceuticals, Inc....
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Xeris Biopharma on the deal. Xeris Biopharma announced a research collaboration and option agreement with Horizon Therapeutics. Under the agreement announced on November...
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
Skadden, Arps, Slate, Meagher & Flom, LLP and Arthur Cox LLP advised Strongbridge, while Goodwin Procter LLP and A&L Goodbody LLP advised Xeris on the deal....
You must be a Standard 1 Year member to access this content.
